Africa scrambles as India vaccine export ban bites | DW | 04.05.2021

Most African countries rely on COVAX, the World Health Organization (WHO) program built to ensure poor countries have equitable access to vaccines to combat the pandemic, for its vaccine supply.

The main supplier, the Serum Institute of India (SII) producers the two-shot AstraZeneca vaccine. But increased domestic demand for doses in India, where the pandemic is currently surging out of control, has interrupted supplies being flown out for COVAX.

Ahmed Ogwell, deputy director of the Africa Centres for Disease Control and Prevention (CDC) called the AstraZeneca vaccine manufactured by the…

Source link

About Author: ACM
This information is 3rd party content that is added to ACM strictly for non-commercial informational purposes. Information is the Key to Set the Black Mind Free